Unity Health Care announced a study to show how health care providers can treat Hepatitis C.
WASHINGTON (WUSA9) -- Hepatitis C is a contagious liver disease,
complications can lead to death. Affecting over 3 million people in the
US, the disease is particularly dangerous because there are few
noticeable symptoms early on.
Wednesday evening, Unity Health Care announced a study to show how health care providers can treat Hepatitis C.
Called the ASCEND study, 600 DC patients will be treated with Harvoni, a newly FDA approved medication. Unity Health Care is partnering with the National Institutes of Health, the University of Maryland, and Family and Medical Counseling Services Inc. to conduct the research.
Labels: Harvoni, trial, Unity Health Care, Washington D.C.